From public to private and back again: sustaining a high service-delivery level during transition of management authority: a Cambodia case study

Health Policy and Planning
Bart JacobsNeil Price

Abstract

Contracting non-governmental organizations (NGOs) has been shown to increase health service delivery output considerably over relatively short time frames in low-income countries, especially when applying performance-related pay as a stimulus. A key concern is how to manage the transition back to government-operated systems while maintaining health service delivery output levels. In this paper we describe and analyse the transition from NGO-managed to government-managed health services over a 3-year period in a health district in Cambodia with a focus on the level of health service delivery. Data are derived from four sources, including cross-sectional surveys and health management and financial information systems. The transition was achieved by focusing on all the building blocks of the health care system and ensuring an acceptable financial remuneration for the staff members of contracted health facilities. The latter was attained through performance subsidies derived from financial commitment by the central government, and revenue from user fees. Performance management had a crucial role in the gradual handover of responsibilities. Not all responsibilities were handed back to government over the case study period-notably th...Continue Reading

References

Jun 1, 2000·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·C Chaix-CouturierP Durieux
Apr 20, 2002·The International Journal of Health Planning and Management·Anne K LaFondKate Macintyre
Feb 13, 2003·Health Policy and Planning·Robert Soeters, Fred Griffiths
Dec 4, 2003·Social Science & Medicine·Hidechika AkashiTakao Sugimoto
Dec 5, 2003·Health Policy and Planning·Bart Jacobs, Neil Price
Dec 10, 2003·The International Journal of Health Planning and Management·Jean-Pierre UngerAndrew Green
Apr 6, 2004·The International Journal of Health Planning and Management·Eric G SarriotMichel C Pacqué
Jun 23, 2004·Health Policy and Planning·Sarah BarberHenk Bekedam
Aug 18, 2004·Health Policy and Planning·Bart Jacobs, Neil Price
Aug 23, 2005·Lancet·Benjamin Loevinsohn, April Harding
Mar 28, 2006·BMJ : British Medical Journal·Natasha PalmerEgbert Sondorp
Aug 15, 2006·Tropical Medicine & International Health : TM & IH·Bruno MeessenJackie Lemlin
Feb 20, 2007·Bulletin of the World Health Organization·Bruno MeessenLaurent Musango
Jul 13, 2007·The International Journal of Health Planning and Management·Bart JacobsSam Oeun Sam
Sep 29, 2007·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·P RenaudinD Ould El Joud
Nov 21, 2007·Bulletin of the World Health Organization·B SabriJ Perrot
Apr 26, 2008·The International Journal of Health Planning and Management·Peter M HansenGilbert Burnham

❮ Previous
Next ❯

Citations

Nov 24, 2012·Health Policy and Planning·Maryam BigdeliWim Van Damme
Oct 24, 2019·Health Policy and Planning·Por IrVirginia Wiseman
Sep 28, 2017·International Journal of Health Policy and Management·Erika L LinnanderElizabeth H Bradley
Oct 23, 2019·BMJ Global Health·Sovanthida SuyMishal S Khan
Sep 6, 2020·Health Economics Review·Elisabeth PaulMarc Bourgeois
Mar 27, 2013·The Journal of the Egyptian Public Health Association·Rasha A MosallamAhmed M Moharram
Dec 24, 2018·Journal of Global Health·György Fritsche, John Peabody
Oct 4, 2020·Global Health, Science and Practice·Nicole RendellEmma Field

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.